探讨肝脏肿瘤切除日归手术的临床疗效。

回顾性收集2026年1月至2月肝脏肿瘤切除日归手术的4例患者临床资料，其中男2例，女2例，年龄42~56岁，肝血管瘤和肝细胞癌各2例；术后随访14 d，分析手术时间、术中出血量、手术方式、术后并发症发生、出院时疼痛程度和满意度等。

4例肝脏肿瘤切除日归手术均顺利完成。手术时间60~84 min，平均术中出血量20 ml，无输血；无严重并发症发生；未实施肝门阻断；未放置腹腔引流管；所有患者均于术后当日出院，出院时疼痛视觉模拟评分为1分。术后14 d内无出血、胆漏、肝功能衰竭等并发症发生，无14 d死亡及再入院发生。

肝脏肿瘤切除日归手术是安全、可行的，可以在成熟的肝胆胰日间手术中心间推广应用。

To investigate the clinical efficacy of liver tumor resection in same-day surgery.

Clinical data were retrospectively collected from 4 patients who underwent hepatectomy for liver tumors from Jan. 2026 to Feb. 2026. The cohort comprised 2 males and 2 females, aged 42-56 years, including 2 cases of hepatic hemangioma and 2 cases of hepatocellular carcinoma. Postoperative follow-up was conducted for 14 days. Parameters analyzed included operative time, intraoperative blood loss, surgical technique, postoperative complications, pain level at discharge, and patient satisfaction, aiming to comprehensively evaluate its clinical applicability.

All 4 same-day surgery hepatectomies for liver tumors were successfully completed. Operative time ranged from 60 to 84 minutes. Intraoperative blood loss was uniformly 20 ml, with no patient requiring a blood transfusion. No severe complications occurred. Portal triad clamping was not performed in any case. No abdominal drainage tubes were placed. All patients were discharged on the day of surgery, reporting a pain score of 1 on the Visual Analog Scale at discharge. Within the 14-day postoperative period, no complications such as hemorrhage, bile leakage, or liver failure were observed. There were no deaths or hospital readmissions within this period.

Hepatectomy for liver tumors performed within same-day surgery is safe and feasible, supporting its broader application in well-established hepatopancreatobiliary day surgery centers.